Depression is associated with abnormalities of the thyroid axis, but t
he role of thyroid hormone therapy is controversial. In patients prese
nting with depression, the thyroid status should be carefully evaluate
d since hypothyroidism can cause depression. Frank hypothyroidism shou
ld be treated in the usual fashion with L-thyroxine, which may reverse
the depressive state. If subclinical hypothyroidism and/or autoimmune
thyroiditis are present, T-3 adjuvant administration (25 mu g/day) sh
ould be seriously considered in patients resistant to tricyclic antide
pressant (TCA) (and probably also) serotonin selective reuptake inhibi
tor (SSRI) medication. The possible efficacy of adjuvant T-4 in revers
ing the depression of such subjects appears less than T-3. In depresse
d patients with TCA or SSRI resistance and no evidence of hypothyroidi
sm, the data available do not establish the therapeutic role of T-3 in
this situation. Multicenter controlled studies of T-3 adjuvant therap
y are required. The possible mechanisms through which T-3 adjuvant the
rapy might be efficacious are discussed.